Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewQ is an AI-driven biotechnology company that leverages quantum computing and advanced artificial intelligence to accelerate the discovery and development of novel therapeutics. The company's proprietary platform integrates quantum mechanics-based simulations with deep learning algorithms to predict molecular interactions and optimize drug candidates with high precision. NewQ primarily focuses on identifying small molecule leads for challenging targets in oncology and immunology. By combining computational efficiency with biological insights, the company aims to significantly reduce the time and cost associated with early-stage drug discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewQ.